Pacira Pharmaceuticals buy Saftman
Start price
22.03.22
/
50%
€64.50
Target price
22.03.23
-
Performance (%)
-43.57%
End price
23.03.23
€36.40
Summary
This prediction ended on 23.03.23 with a price of €36.40. The BUY prediction by Saftman for Pacira Pharmaceuticals performed very badly with a performance of -43.57%. Saftman has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Pacira Pharmaceuticals | 12.295% | 12.295% | -27.895% |
iShares Core DAX® | 2.749% | 4.620% | 17.121% |
iShares Nasdaq 100 | 0.470% | -0.331% | 37.776% |
iShares Nikkei 225® | -2.930% | -5.556% | 12.185% |
iShares S&P 500 | 0.679% | 0.631% | 28.996% |
Comments by Saftman for this prediction
In the thread Pacira Pharmaceuticals diskutieren
Saftman hat das Wertpapier Pacira Pharmaceuticals in seinem Wikifolio Langfristige Aufwärtstrends gekauft.
In the thread Trading Pacira Pharmaceuticals
Die von Saftman gewählte maximale Laufzeit wurde überschritten